The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes
Open accessThe DOI matches its Crossref record; 176 of the 177 references it cites were found in a registry or an index; 17 of the 166 sources its claims cite were checked for support.
Abstract
The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes have been debated extensively. The concept that a feedback loop governs the interaction of the insulin-sensitive tissues and the beta cell as well as the elucidation of the hyperbolic relationship between insulin sensitivity and insulin secretion explains why insulin-resistant subjects exhibit markedly increased insulin responses while those who are insulin-sensitive have low responses. Consideration of this hyperbolic relationship has helped identify the critical role of beta-cell dysfunction in the development of Type 2 diabetes and the demonstration of reduced beta-cell function in high risk subjects. Furthermore, assessments in a number of ethnic groups emphasise that beta-cell function is a major determinant of oral glucose tolerance in subjects with normal and reduced glucose tolerance and that in all populations the progression from normal to impaired glucose tolerance and subsequently to Type 2 diabetes is associated with declining insulin sensitivity and beta-cell function. The genetic and molecular basis for these reductions in insulin sensitivity and beta-cell function are not fully understood but it does seem that body-fat distribution and especially intra-abdominal fat are major determinants of insulin resistance while reductions in beta-cell mass contribute to beta-cell dysfunction. Based on our greater understanding of the relative roles of insulin resistance and beta-cell dysfunction in Type 2 diabetes, we can anticipate advances in the identification of genes contributing to the development of the disease as well as approaches to the treatment and prevention of Type 2 diabetes.
Overview
CoChat Summary
TL;DR
This review argues that insulin resistance and beta-cell dysfunction are both present early in the natural history of Type 2 diabetes, and that beta-cell function must be interpreted relative to insulin sensitivity through the hyperbolic/disposition-index relationship. It concludes that progressive beta-cell failure is a major determinant of worsening glucose tolerance, while intra-abdominal fat is a key determinant of insulin resistance.
Key findings
- The relationship between insulin sensitivity and insulin secretion is non-linear and best described as hyperbolic; the product of insulin sensitivity and insulin response (disposition index) is constant for a given degree of glucose tolerance. This was shown in 93 healthy subjects younger than 45 years and confirmed in Danish and Pima Indian cohorts.
- In 531 first-degree relatives of Type 2 diabetic subjects from four ethnic groups, beta-cell function adjusted for insulin sensitivity accounted for 45% of the variance in glucose disposal, compared with 8% for insulin sensitivity alone and 29% for the early insulin response alone. Among subjects with normal glucose tolerance, those with poorer glucose disposal had reduced beta-cell function but no difference in insulin sensitivity.
- In Pima Indians followed for an average of 5 years, those progressing to diabetes had a 78% decline in insulin secretion while insulin sensitivity decreased by only 14%; non-progressors had an 11% decrease in insulin sensitivity accompanied by a 30% increase in insulin secretion.
- Intra-abdominal fat was the strongest correlate of insulin sensitivity, explaining 47% of its variance in 174 subjects. Prevention trials cited include DPP lifestyle intervention reducing diabetes development by 58% and metformin by 31%, STOP-NIDDM acarbose by 25%, and TRIPOD troglitazone by 55%; in UKPDS, after 9 years only 25% of the intensive-treatment arm achieved HbA1c below 7% with monotherapy.
Methods
- Narrative review based on English-language literature published during 1990–2001 and seminal prior contributions, integrated with PubMed searches for “insulin resistance, diabetes and humans” and “insulin secretion, diabetes and humans.”
- Synthesizes cross-sectional and longitudinal human studies, including a 174-subject cohort (73 men/101 women, age 30–75 years), 531 first-degree relatives from four ethnic groups, and Pima Indian follow-up data; no new primary data are reported.
Limitations
- Stated: the genetic and molecular basis for reductions in insulin sensitivity and beta-cell function are not fully understood; the mechanism(s) by which body-fat distribution influences insulin sensitivity are unclear; whether beta-cell regulation is governed by a central neural process or a humoral signal is unknown; and mechanisms by which lifestyle or metformin reduced diabetes development in prevention studies had not yet been reported.
- Stated: at the time of writing, no known pharmacological intervention was capable of preventing the progressive decline in beta-cell function in Type 2 diabetic patients.
- Evident: as a narrative review, it does not use a systematic search or meta-analysis and relies on heterogeneous observational and intervention studies, limiting causal inference.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
14 Valid · 1 Not valid · 64 Not checked · 42 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Our finding of a hyperbolic relationship between insulin sensitivity and insulin secretion in healthy subjects has been confirmed in large cohorts of Danish [94] and Pima Indian subjects [95].”
What the sources say
- Disputedcites [94] 94. Clausen JO, Borch-Johnsen K, Ibsen H et al. (1996) Insulin sensitivity index, acute insulin response, and glucose effectiveness in a population-based sample of 380 young healthy Caucasians. Analysis of the impact of gender, body fat, physical fitness, and life-style factors. J Clin Invest 98:1195-1209 sourceExperimental — accuracy not yet measured
Our copy of Clausen et al. (1996) does report a large, population-based Danish sample (380 young healthy Caucasians, Results/Table II), but on the decisive point it says the opposite of confirmation: in the discussion of the insulin sensitivity index vs. insulin secretion it states 'we were not able to demonstrate from a statistical perspective that the hyperbola was the best analytic function to account for the data in our population,' noting a straight line with negative slope or a parabola fits equally or better (Figure 5 section). The Results add that 'a standard linear model gives a significantly better description than the other models' and that adding a parabolic term improved the fit significantly, and that the coefficient of variation of the product (0.60) was not lower than that of the individual variables (0.61 and 0.70), i.e. the disposition index was not a constant. The authors explain that because the cohort contained only young, relatively lean subjects the 'rising limb' of the hyperbola was never observed and they lacked 'a broad enough population base ... to have power to determine the best function.' Thus citing this paper as confirming the hyperbolic relationship in a large Danish cohort is contradicted by the paper itself. (LLM, conf=0.87)
Checked by a reasoning model — may be wrong.
- Supportedcites [95] 95. Weyer C, Bogardus C, Mott DM, Pratley RE (1999) The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 104:787-794 source
In 'Relation between changes in insulin secretion and insulin action' our copy states that a hyperbolic relationship between early insulin secretion and insulin action is well known in individuals with normal glucose tolerance and that 'Figure 2 depicts this hyperbolic relationship between AIR and M-low in 277 Pima Indians with NGT'; the Figure 2 legend likewise gives the regression between AIR and M-low derived from a reference population of 277 Pima Indians with NGT. This supplies the Pima Indian half of the claim (large cohort, healthy/NGT subjects); the Danish cohort is carried by the separate citation [94] and is not part of what is attributed to this source. The paper's disposition-index results (nonprogressors' compensatory rise in AIR with falling M-low) further corroborate the hyperbolic compensation relationship. (LLM, conf=0.85)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“it has become apparent that the relationship between BMI and insulin sensitivity is non-linear, rather than linear as had been traditionally thought.”
What the sources say
- Not checked yetcites [54] 54. Kahn SE, Prigeon RL, McCulloch DK et al. (1993) Quantification of the relationship between insulin sensitivity and B-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42:1663-1672 source
- Partly supportedcites [38] 38. Cnop M, Landchild MJ, Vidal J et al. (2002) The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations: distinct metabolic effects of two fat compartments. Diabetes 51:1005-1015 sourceExperimental — accuracy not yet measured
The Methods say the relationships between insulin sensitivity and untransformed measures of body fat appeared nonlinear, and the Results report an inverse correlation with BMI. However, the paper specifically tests and confirms nonlinearity for intra-abdominal fat, not BMI, and does not establish that a linear BMI relationship was traditionally assumed. (LLM, conf=0.82)
plainstates an associationn = 174- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“These findings derived from cross-sectional data are supported by a longitudinal study in Pima Indians that has also shown the importance of accounting for the hyperbolic relationship between insulin sensitivity and insulin secretion and demonstrated the presence of impaired beta-cell function in those destined to progress to Type 2 diabetes [95].”
What the sources say
- Supportedcites [95] 95. Weyer C, Bogardus C, Mott DM, Pratley RE (1999) The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 104:787-794 source
In “Relation between changes in insulin secretion and insulin action” (page not provided), the paper reports that insulin secretion was already too low relative to insulin resistance in Pima Indian participants who later developed diabetes, even while they had normal glucose tolerance. It uses the hyperbolic relationship between insulin secretion and action to make that assessment. (LLM, conf=0.93)
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“As postulated previously [93], we found that the relationship between insulin sensitivity and insulin secretion is non-linear and best described by a hyperbolic function.”
What the sources say
- Partly supportedcites [93] 93. Bergman RN, Phillips LS, Cobelli C (1981) Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and β -cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 68:1456-1467 sourceExperimental — accuracy not yet measured
Figure 5 (Discussion, p. 9) plots second-phase pancreatic responsiveness against insulin sensitivity and shows a constant-product line, φ2·S = 75, which is hyperbolic. The passage uses that line to distinguish glucose-tolerance regions; it does not say the observed relationship between insulin sensitivity and secretion was best described by a hyperbolic function. (LLM, conf=0.83)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“obesity and its associated insulin resistance are associated with basal and stimulated hyperinsulinaemia [10, 68, 91, 92].”
What the sources say
- Not checked yetcites [10] 10. Beard JC, Ward WK, Halter JB, Wallum BJ, Porte D Jr (1987) Relationship of islet function to insulin action in human obesity. J Clin Endocrinol Metab 65:59-64 source
- Partly supportedcites [68] 68. Perley MJ, Kipnis DM (1967) Plasma insulin responses to oral and intravenous glucose: studies in normal and diabetic subjects. J Clin Invest 46:1954-1962 sourceExperimental — accuracy not yet measured
The Results report excessive glucose-stimulated plasma insulin responses in obese subjects, and the discussion describes significant insulin antagonism associated with obesity. The passages do not establish basal hyperinsulinaemia; a search for basal and fasting insulin found no group comparison of basal levels. Page numbers are unavailable in our copy. (LLM, conf=0.87)
- Not checked yetcites [91] 91. Karam JH, Grodsky GM, Forsham PH (1963) Excessive insulin response to glucose in obese subjects as measured by immunochemical assay. Diabetes 12:197-204 source
- Not checked yetcites [92] 92. Bagdade JD, Porte D Jr, Brunzell JD, Bierman EL (1974) Basal and stimulated hyperinsulinism: reversible metabolic sequelae of obesity. J Lab Clin Med 83:563-569
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
66 more claims · 7 with their cited sources checked
Create a free account to see all 121 claims and to verify the 149 references still open.
- It may state two separate claims as one. 47
- Probably not a substantial claim. 2
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Such a decrease in second phase insulin secretion would take more than a decade to emerge in most T2DM patients presenting in middle or later life [21][22] .”
From Type 2 diabetes in adolescents and young adults (2018) · cites this paper as [22]
Experimental — accuracy not yet measuredIn the citing paper
“β-cell function however cannot be characterised solely on the basis of insulin secretion without the consideration of the underlying insulin resistance.”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [47]
In the citing paper
“According to this concept, the relation between insulin secretion and insulin sensitivity is hyperbolic; the ratio of incremental insulin over incremental glucose divided by insulin resistance is described by a constant, the disposition index.39,47”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [47]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Insulin resistance and beta-cell dysfunction: where are we now and what does the future hold? · p. 12
“Two more large prevention studies examining the effects of the insulin sensitizer rosiglitazone [163] and the beta-cell secretagogue nateglinide [164]”
§ References · p. 17
“163. Yusuf S, Gerstein H, Hoogwerf B et al. (2001) Ramipril and the development of diabetes.”
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873 · cited 1×
“This Swedish study provided the basis for the design of the Da Qing study in China [158], the Finnish Diabetes Prevention Study [159] and the DPP carried out in the United States [16].”
MethodReport of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,338
(1998) · PsycEXTRA Dataset · doi:10.1037/e565682010-001 · Cited by 9,472
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Central nervous system control of food intake
Schwartz, M. W., Woods, S. C., Porte, D., Seeley, R. J., & Baskin, D. G. (2000) · Nature · doi:10.1038/35007534 · Cited by 6,451 · cited 1×
“glucose, lipid and protein metabolism, insulin also has important central nervous system effects, where its action in the hypothalamus reduces food intake and increases energy expenditure [155].”
BackgroundGlobal Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections
King, H., Aubert, R. E., & Herman, W. H. (1998) · Diabetes Care · doi:10.2337/diacare.21.9.1414 · Cited by 6,311
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1183 · Cited by 6,220
The hormone resistin links obesity to diabetes
Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., Patel, H. R., Ahima, R. S., & Lazar, M. A. (2001) · Nature · doi:10.1038/35053000 · Cited by 4,755
DeFronzo, R. A., & Ferrannini, E. (1991) · Diabetes Care · doi:10.2337/diacare.14.3.173 · Cited by 4,535
Pan, X.-R., Li, G.-W., Hu, Y.-H., Wang, J.-X., Yang, W.-Y., An, Z.-X., Hu, Z.-X., Juan-Lin, Xiao, J.-Z., Cao, H.-B., et al. (1997) · Diabetes Care · doi:10.2337/diacare.20.4.537 · Cited by 4,320
Gupta, A., & Uribarri, J. (2016) · Hormone Research in Paediatrics · doi:10.1159/000444053 · Cited by 4,006
Weyer, C., Funahashi, T., Tanaka, S., Hotta, K., Matsuzawa, Y., Pratley, R. E., & Tataranni, P. A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.5.7463 · Cited by 3,541
Plasma Concentrations of a Novel, Adipose-Specific Protein, Adiponectin, in Type 2 Diabetic Patients
Hotta, K., Funahashi, T., Arita, Y., Takahashi, M., Matsuda, M., Okamoto, Y., Iwahashi, H., Kuriyama, H., Ouchi, N., Maeda, K., et al. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.6.1595 · Cited by 3,133
(1998) · PubMed · Cited by 2,737
(1998) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/68.4.899 · Cited by 2,700
Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial
Chiasson, J.-L., Josse, R. G., Gomis, R., Hanefeld, M., Karasik, A., & Laakso, M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08905-5 · Cited by 2,543
Turner, R. C. (1999) · JAMA · doi:10.1001/jama.281.21.2005 · Cited by 2,375 · cited 1×
“Thus, after 9 years only 25% of the subjects in the intensive treatment arm were achieving a HbA1c of less than 7% with monotherapy alone [14, 15].”
BackgroundWeyer, C., Bogardus, C., Mott, D. M., & Pratley, R. E. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7231 · Cited by 1,940 · cited 4×
“Based on the UKPDS [18] and the longitudinal assessment in Pima Indians [95], the major reason for the decline in glucose tolerance seems to be a progressive loss of beta-cell function.”
MethodResultInfluentialThe common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes
Altshuler, D., Hirschhorn, J. N., Klannemark, M., Lindgren, C. M., Vohl, M.-C., Nemesh, J., Lane, C. R., Schaffner, S. F., Bolk, S., Brewer, C., et al. (2000) · Nature Genetics · doi:10.1038/79216 · Cited by 1,766
Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM
Boden, G. (1997) · Diabetes · doi:10.2337/diab.46.1.3 · Cited by 1,728
Prevalence of impaired glucose tolerance among children and adolescents with marked obesity
Sinha, R., Fisch, G., Teague, B., Tamborlane, W. V., Banyas, B., Allen, K., Savoye, M., Rieger, V., Taksali, S., Barbetta, G., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012578 · Cited by 1,709
Bergman, R. N., Phillips, L. S., & Cobelli, C. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110398 · Cited by 1,640 · cited 2×
“As postulated previously [93], we found that the relationship between insulin sensitivity and insulin secretion is non-linear and best described by a hyperbolic function.”
BackgroundMechanism of free fatty acid-induced insulin resistance in humans.
Roden, M., Price, T. B., Perseghin, G., Petersen, K. F., Rothman, D. L., Cline, G. W., & Shulman, G. I. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118742 · Cited by 1,539 · cited 1×
“In vivo, infusion of lipid emulsions and heparin in healthy subjects increased plasma NEFA concentrations to above the physiological range and were associated with the development of insulin resistance, an effect mediated by changes in post-receptor insulin signalling [149, 150, 151].”
BackgroundLillioja, S., Mott, D. M., Spraul, M., Ferraro, R., Foley, J. E., Ravussin, E., Knowler, W. C., Bennett, P. H., & Bogardus, C. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312303292703 · Cited by 1,508 · cited 1×
“Thus, re-examination of data from some other studies of high risk subjects with NGT would suggest that the conclusions in those papers disputing the presence of beta-cell dysfunction are erroneous because no difference in the insulin responses existed between groups despite the presence of insulin resistance, indicati…”
ResultKahn, S. E., Prigeon, R. L., McCulloch, D. K., Boyko, E. J., Bergman, R. N., Schwartz, M. W., Neifing, J. L., Ward, W. K., Beard, J. C., & Palmer, J. P. (1993) · Diabetes · doi:10.2337/diab.42.11.1663 · Cited by 1,405 · cited 7×
“The percentile score was determined based on the formula derived in a separate healthy population [54].”
BackgroundMethodResultInfluentialSelf-citationBarroso, I., Gurnell, M., Crowley, V. E. F., Agostini, M., Schwabe, J. W., Soos, M. A., Maslen, G. L., Williams, T. D. M., Lewis, H., Schafer, A. J., et al. (1999) · Nature · doi:10.1038/47254 · Cited by 1,368 · cited 3×
“For instance, in a cohort of markedly insulin-resistant subjects, two different dominant negative mutations of the peroxisome proliferator activating receptor gamma (PPAR-γ) receptor could only explain less than 4% of these cases [20], with the effect of this mutation on obesity and diabetes being debated [45, 46, 47].”
BackgroundBuchanan, T. A., Xiang, A. H., Peters, R. K., Kjos, S. L., Marroquin, A., Goico, J., Ochoa, C., Tan, S., Berkowitz, K., Hodis, H. N., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.9.2796 · Cited by 1,339
Deeb, S. S., Fajas, L., Nemoto, M., Pihlajamäki, J., Mykkänen, L., Kuusisto, J., Laakso, M., Fujimoto, W., & Auwerx, J. (1998) · Nature Genetics · doi:10.1038/3099 · Cited by 1,319
Cooper, G. J., Willis, A. C., Clark, A., Turner, R. C., Sim, R. B., & Reid, K. B. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.23.8628 · Cited by 1,299
Griffin, M. E., Marcucci, M. J., Cline, G. W., Bell, K., Barucci, N., Lee, D., Goodyear, L. J., Kraegen, E. W., White, M. F., & Shulman, G. I. (1999) · Diabetes · doi:10.2337/diabetes.48.6.1270 · Cited by 1,267
Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease.
Després, J. P., Moorjani, S., Lupien, P. J., Tremblay, A., Nadeau, A., & Bouchard, C. (1990) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.10.4.497 · Cited by 1,248
Martin, B. C., Warram, J. H., Krolewski, A. S., Soeldner, J. S., Kahn, C. R., Martin, B. C., & Bergman, R. N. (1992) · The Lancet · doi:10.1016/0140-6736(92)92814-v · Cited by 1,158 · cited 1×
“Thus, re-examination of data from some other studies of high risk subjects with NGT would suggest that the conclusions in those papers disputing the presence of beta-cell dysfunction are erroneous because no difference in the insulin responses existed between groups despite the presence of insulin resistance, indicati…”
ResultEriksson, K. F., & Lindg�rde, F. (1991) · Diabetologia · doi:10.1007/bf00400196 · Cited by 1,092 · cited 1×
“This effect was first shown in a feasibility study in Malmö, Sweden [157].”
Warram, J. H., Martin, B. C., Krolewski, A. S., Soeldner, J. S., & Kahn, C. R. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-12-909 · Cited by 1,038
Emerging epidemic of type 2 diabetes in youth
Rosenbloom, A. L., Joe, J. R., Young, R. S., & Winter, W. E. (1999) · Diabetes Care · doi:10.2337/diacare.22.2.345 · Cited by 1,019 · cited 1×
“This is due to the emergence of Type 2 diabetes as a new and very serious health problem in children [11, 12].”
BackgroundWestermark, P., Wernstedt, C., Wilander, E., Hayden, D. W., O'Brien, T. D., & Johnson, K. H. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.11.3881 · Cited by 976
Plasma Insulin Responses to Oral and Intravenous Glucose: Studies in Normal and Diabetic Subjects*
Perley, M. J., & Kipnis, D. M. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105685 · Cited by 917 · cited 2×
“From shortly after the development of the insulin RIA, it has been well recognised that obesity and its associated insulin resistance are associated with basal and stimulated hyperinsulinaemia [10, 68, 91, 92].”
BackgroundProtein–protein interaction in insulin signaling and the molecular mechanisms of insulin resistance
Virkamäki, A., Ueki, K., & Kahn, C. R. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6609 · Cited by 854 · cited 1×
“Despite tremendous advances in molecular biology and the continued identification of increasingly more molecules involved in the insulin signalling cascade [19], the molecular mechanism(s) that underlies the development of insulin resistance in humans still remains elusive.”
BackgroundFreeman, D. J., Norrie, J., Sattar, N., Neely, R. D. G., Cobbe, S. M., Ford, I., Isles, C., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., et al. (2001) · Circulation · doi:10.1161/01.cir.103.3.357 · Cited by 844
Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation.
Westermark, P., Engström, U., Johnson, K. H., Westermark, G. T., & Betsholtz, C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.13.5036 · Cited by 807
Early Metabolic Defects in Persons at Increased Risk for Non-Insulin-Dependent Diabetes Mellitus
Eriksson, J., Franssila-Kallunki, A., Ekstrand, A., Saloranta, C., Widén, E., Schalin, C., & Groop, L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198908103210601 · Cited by 807 · cited 1×
“Thus, re-examination of data from some other studies of high risk subjects with NGT would suggest that the conclusions in those papers disputing the presence of beta-cell dysfunction are erroneous because no difference in the insulin responses existed between groups despite the presence of insulin resistance, indicati…”
ResultAltshuler, D., Daly, M., & Kruglyak, L. (2000) · Nature Genetics · doi:10.1038/79839 · Cited by 762
Relationships of generalized and regional adiposity to insulin sensitivity in men.
Abate, N., Garg, A., Peshock, R. M., Stray-Gundersen, J., & Grundy, S. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118083 · Cited by 759
Measurement of Plasma Glucose, Free Fatty Acid, Lactate, and Insulin for 24 h in Patients With NIDDM
Reaven, G. M., Hollenbeck, C., Jeng, C.-Y., Wu, M. S., & Chen, Y.-D. I. (1988) · Diabetes · doi:10.2337/diab.37.8.1020 · Cited by 753
(1999) · Diabetes Care · doi:10.2337/diacare.22.4.623 · Cited by 725
Zhou, Y. P., & Grill, V. E. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117042 · Cited by 677 · cited 1×
“Exposure to NEFA in vitro decreased insulin-mediated glucose uptake and glycogen synthesis [146] as well as reduced beta-cell function [147, 148], encompassing both reduced insulin release and impaired proinsulin to insulin processing.”
BackgroundBagdade, J. D., Bierman, E. L., & Porte, D. (1967) · Journal of Clinical Investigation · doi:10.1172/jci105646 · Cited by 672 · cited 1×
“This change is manifest in a number of different ways including decreases in the insulin response to intravenous glucose [68, 69, 70] and a decline in the ability of glucose to potentiate the insulin response to nonglucose secretagogues such as the amino acid arginine [71], hormones such as secretin [72], the β-adrene…”
BackgroundMechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects.
Kolterman, O. G., Insel, J., Saekow, M., & Olefsky, J. M. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109790 · Cited by 664
The Importance of β-Cell Failure in the Development and Progression of Type 2 Diabetes
Kahn, S. E. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.9.7713 · Cited by 660
Self-citationVisceral Obesity in Men: Associations With Glucose Tolerance, Plasma Insulin, and Lipoprotein Levels
Pouliot, M.-C., Després, J.-P., Nadeau, A., Moorjani, S., Prud'Homme, D., Lupien, P. J., Tremblay, A., & Bouchard, C. (1992) · Diabetes · doi:10.2337/diab.41.7.826 · Cited by 635
Phillips, D. I. W., Clark, P. M., Hales, C. N., & Osmond, C. (1994) · Diabetic Medicine · doi:10.1111/j.1464-5491.1994.tb00273.x · Cited by 631 · cited 1×
“To account for the small variations in the magnitude of the glucose stimulus that provokes this early insulin response, it has been divided by the increment in plasma glucose over the same time period [125].”
BackgroundPPARγ, the ultimate thrifty gene
Auwerx, J. (1999) · Diabetologia · doi:10.1007/s001250051268 · Cited by 612
Effects of weight loss on regional fat distribution and insulin sensitivity in obesity.
Goodpaster, B. H., Kelley, D. E., Wing, R. R., Meier, A., & Thaete, F. L. (1999) · Diabetes · doi:10.2337/diabetes.48.4.839 · Cited by 608
MATSUZAWA, Y., FUNAHASHI, T., & NAKAMURA, T. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07793.x · Cited by 597
Glucose Intolerance and Aging: Evidence for Tissue Insensitivity to Insulin
DeFronzo, R. A. (1979) · Diabetes · doi:10.2337/diab.28.12.1095 · Cited by 595
Mitrakou, A., Kelley, D., Mokan, M., Veneman, T., Pangburn, T., Reilly, J., & Gerich, J. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201023260104 · Cited by 595 · cited 18×
“In this large cohort, using recently defined criteria [127], only 45% had NGT with 36% meeting the criteria for IFG and/or IGT and 19% the criteria for diabetes.”
BackgroundInfluentialExcessive Insulin Response to Glucose in Obese Subjects as Measured by Immunochemical Assay
Karam, J. H., Grodsky, G. M., Forsham, P. H., & McWilliams, N. B. (1963) · Diabetes · doi:10.2337/diab.12.3.197 · Cited by 591
β-cells in type II diabetes mellitus
Porte, D. (1991) · Diabetes · doi:10.2337/diab.40.2.166 · Cited by 585
Impaired Glucose Tolerance as a Disorder of Insulin Action
Lillioja, S., Mott, D. M., Howard, B. V., Bennett, P. H., Yki-Järvinen, H., Freymond, D., Nyomba, B. L., Zurlo, F., Swinburn, B., & Bogardus, C. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805123181901 · Cited by 578 · cited 1×
“Thus, re-examination of data from some other studies of high risk subjects with NGT would suggest that the conclusions in those papers disputing the presence of beta-cell dysfunction are erroneous because no difference in the insulin responses existed between groups despite the presence of insulin resistance, indicati…”
ResultAbnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus.
Polonsky, K. S., Given, B. D., Hirsch, L. J., Tillil, H., Shapiro, E. T., Beebe, C., Frank, B. H., Galloway, J. A., & Van Cauter, E. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805123181903 · Cited by 567 · cited 1×
“In addition, alterations in pulsatile insulin release [74, 75] and ultradian oscillatory insulin secretion [76] can be observed.”
BackgroundRamipril and the Development of Diabetes
Yusuf, S. (2001) · JAMA · doi:10.1001/jama.286.15.1882 · Cited by 541 · cited 2×
“Two more large prevention studies examining the effects of the insulin sensitizer rosiglitazone [163] and the beta-cell secretagogue nateglinide [164] have been initiated and should provide further insight into the potential for primary prevention of Type 2 diabetes using approaches that tackle the fundamental defects…”
BackgroundImpaired Pulsatile Secretion of Insulin in Relatives of Patients with Non-Insulin-Dependent Diabetes
O'Rahilly, S., Turner, R. C., & Matthews, D. R. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805123181902 · Cited by 540 · cited 2×
“Studies in subjects at high risk including first degree relatives of subjects with Type 2 diabetes [121, 122], women with a history of gestational diabetes [100] or polycystic ovarian disease [96] and subjects with IGT [123, 124] have shown reductions in the later (second-phase) insulin response to intravenous glucose…”
BackgroundBRUNZELL, J. D., ROBERTSON, R. P., LERNER, R. L., HAZZARD, W. R., ENSINCK, J. W., BIERMAN, E. L., & PORTE, D. (1976) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-42-2-222 · Cited by 505
Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes.
Kahn, S. E., Andrikopoulos, S., & Verchere, C. B. (1999) · Diabetes · doi:10.2337/diabetes.48.2.241 · Cited by 488 · cited 1×
“One factor that we and others have been examining is the deposition of amyloid, which is found in the islets of up to 90% of patients with Type 2 diabetes [128, 129].”
BackgroundSelf-citationThe Effect of Insulin Treatment on Insulin Secretion and Insulin Action in Type II Diabetes Mellitus
Garvey, W. T., Olefsky, J. M., Griffin, J., Hamman, R. F., & Kolterman, O. G. (1985) · Diabetes · doi:10.2337/diab.34.3.222 · Cited by 488
Visceral Obesity: A “Civilization Syndrome”
Björntorp, P. (1993) · Obesity Research · doi:10.1002/j.1550-8528.1993.tb00614.x · Cited by 483
Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus
Ward, W. K., Bolgiano, D. C., McKnight, B., Halter, J. B., & Porte, D. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111542 · Cited by 483 · cited 1×
“This change is manifest in a number of different ways including decreases in the insulin response to intravenous glucose [68, 69, 70] and a decline in the ability of glucose to potentiate the insulin response to nonglucose secretagogues such as the amino acid arginine [71], hormones such as secretin [72], the β-adrene…”
BackgroundEvidence of Cosecretion of Islet Amyloid Polypeptide and Insulin by β-Cells
Kahn, S. E., D'Alessio, D. A., Schwartz, M. W., Fujimoto, W. Y., Ensinck, J. W., Taborsky, G. J., & Porte, D. (1990) · Diabetes · doi:10.2337/diab.39.5.634 · Cited by 454
Self-citationFerrannini, E. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.4.0336 · Cited by 451 · cited 1×
“Thus, re-examination of data from some other studies of high risk subjects with NGT would suggest that the conclusions in those papers disputing the presence of beta-cell dysfunction are erroneous because no difference in the insulin responses existed between groups despite the presence of insulin resistance, indicati…”
ResultDunaif, A. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.3.942 · Cited by 450
Rizza, R. A., Mandarino, L. J., & Gerich, J. E. (1982) · Diabetes · doi:10.2337/diab.31.8.663 · Cited by 440 · cited 2×
“What has become apparent is that insulin sensitivity is influenced by a number of different factors such as genetics [20], age [21, 22], acute exercise [23], physical fitness [24], dietary nutrients [25], medications [26, 27, 28], obesity [9, 10, 29, 30, 31, 32] and body fat distribution [31, 33, 34, 35, 36, 37, 38].”
BackgroundCnop, M., Landchild, M. J., Vidal, J., Havel, P. J., Knowles, N. G., Carr, D. R., Wang, F., Hull, R. L., Boyko, E. J., Retzlaff, B. M., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1005 · Cited by 432
Self-citationEhrmann, D. A., Sturis, J., Byrne, M. M., Karrison, T., Rosenfield, R. L., & Polonsky, K. S. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118064 · Cited by 426 · cited 3×
“Thus, first-degree relatives of patients with Type 2 diabetes [96, 97, 98], women with a history of gestational diabetes [99, 100, 101] or polycystic ovarian disease [96, 102], older subjects [22, 24, 103] and subjects with impaired glucose tolerance [104, 105] can all be shown to have beta-cell dysfunction, manifest…”
BackgroundAdiposity, Fat Distribution, and Cardiovascular Risk
Peiris, A. N., Sothmann, M. S., Hoffmann, R. G., Hennes, M. I., Wilson, C. R., Gustafson, A. B., & Kissebah, A. H. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-110-11-867 · Cited by 423
Yang, W.-S., Jeng, C.-Y., Wu, T.-J., Tanaka, S., Funahashi, T., Matsuzawa, Y., Wang, J.-P., Chen, C.-L., Tai, T.-Y., & Chuang, L.-M. (2002) · Diabetes Care · doi:10.2337/diacare.25.2.376 · Cited by 405
Lukinius, A., Wilander, E., Westermark, G. T., Engstr�m, U., & Westermark, P. (1989) · Diabetologia · doi:10.1007/bf00285291 · Cited by 371 · cited 1×
“IAPP is co-localized within the same secretory granules as insulin [115] and is typically co-released with insulin in vitro in response to glucose and non-glucose secretagogues [116, 117].”
BackgroundAssociation of the T-G Polymorphism in Adiponectin (Exon 2) With Obesity and Insulin Sensitivity
Stumvoll, M., Tschritter, O., Fritsche, A., Staiger, H., Renn, W., Weisser, M., Machicao, F., & Häring, H. (2002) · Diabetes · doi:10.2337/diabetes.51.1.37 · Cited by 371 · cited 1×
“Examination of groups of healthy subjects in a number of different populations has shown that known genetic mutations associated with insulin resistance are rare [20, 39, 40, 41, 42, 43, 44].”
BackgroundYki‐Järvinen, H. (1992) · Endocrine Reviews · doi:10.1210/er.13.3.415 · Cited by 368
CHEN, M., BERGMAN, R. N., PACINI, G., & PORTE, D. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-60-1-13 · Cited by 353
Splanchnic insulin metabolism in obesity. Influence of body fat distribution.
Peiris, A. N., Mueller, R. A., Smith, G. A., Struve, M. F., & Kissebah, A. H. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112758 · Cited by 346 · cited 2×
“What has become apparent is that insulin sensitivity is influenced by a number of different factors such as genetics [20], age [21, 22], acute exercise [23], physical fitness [24], dietary nutrients [25], medications [26, 27, 28], obesity [9, 10, 29, 30, 31, 32] and body fat distribution [31, 33, 34, 35, 36, 37, 38].”
BackgroundWELCH, S., GEBHART, S. S. P., BERGMAN, R. N., & PHILLIPS, L. S. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-6-1508 · Cited by 337
Yalow, R. S., & Berson, S. A. (1960) · Diabetes · doi:10.2337/diab.9.4.254 · Cited by 330
Jensen, C. C., Cnop, M., Hull, R. L., Fujimoto, W. Y., Kahn, S. E., & the American Diabetes Association GENNID Study Group (2002) · Diabetes · doi:10.2337/diabetes.51.7.2170 · Cited by 312
Self-citationMutations in the Insulin Receptor Gene
TAYLOR, S. I., CAMA, A., ACCILI, D., BARBETTI, F., QUON, M. J., SIERRA, M. D. L. L., SUZUKI, Y., ROLLER, E., LEVY-TOLEDANO, R., WERTHEIMER, E., et al. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-3-566 · Cited by 311
Relationship of Generalized and Regional Adiposity to Insulin Sensitivity in Men With NIDDM
Abate, N., Garg, A., Peshock, R. M., Stray-Gundersen, J., Adams-Huet, B., & Grundy, S. M. (1996) · Diabetes · doi:10.2337/diab.45.12.1684 · Cited by 297
Effect of troglitazone on body fat distribution in type 2 diabetic patients.
Mori, Y., Murakawa, Y., Okada, K., Horikoshi, H., Yokoyama, J., Tajima, N., & Ikeda, Y. (1999) · Diabetes Care · doi:10.2337/diacare.22.6.908 · Cited by 281
Verchere, C. B., D'Alessio, D. A., Palmiter, R. D., Weir, G. C., Bonner-Weir, S., Baskin, D. G., & Kahn, S. E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3492 · Cited by 278 · cited 1×
“Studies using human IAPP transgenic mice suggest that consumption of increased dietary fat [133] or marked overproduction of IAPP [134, 135] could be important factors in triggering the commencement of islet amyloidogenesis.”
BackgroundSelf-citationTYPE 2 DIABETES MELLITUS IN MINORITY CHILDREN AND ADOLESCENTS
Dabelea, D., Pettitt, D. J., Jones, K. L., & Arslanian, S. A. (1999) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70098-0 · Cited by 276
Ward, W. K., LaCava, E. C., Paquette, T. L., Beard, J. C., Wallum, B. J., & Porte, D. (1987) · Diabetologia · doi:10.1007/bf00296991 · Cited by 275 · cited 1×
“Finally, inefficient proinsulin processing to insulin [77, 78, 79, 80, 81, 82, 83] and a reduction in the release of islet amyloid polypeptide (IAPP), known also as amylin [84, 85, 86, 87], have been observed in established Type 2 diabetes.”
BackgroundThe effect of intensive endurance exercise training on body fat distribution in young and older men
Schwartz, R. S., Shuman, W. P., Larson, V., Cain, K. C., Fellingham, G. W., Beard, J. C., Kahn, S. E., Stratton, J. R., Cerqueira, M. D., & Abrass, I. B. (1991) · Metabolism · doi:10.1016/0026-0495(91)90239-s · Cited by 275 · cited 1×
“In this study exercise training resulted in a 25% reduction in intra-abdominal fat area and a 36% improvement in insulin sensitivity [24, 62].”
BackgroundSelf-citationEffects of a 48-h Fat Infusion on Insulin Secretion and Glucose Utilization
Boden, G., Chen, X., Rosner, J., & Barton, M. (1995) · Diabetes · doi:10.2337/diab.44.10.1239 · Cited by 271
Clausen, J. O., Borch-Johnsen, K., Ibsen, H., Bergman, R. N., Hougaard, P., Winther, K., & Pedersen, O. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118903 · Cited by 259
Acute enhancement of insulin secretion by FFA in humans is lost with prolonged FFA elevation
Carpentier, A., Mittelman, S. D., Lamarche, B., Bergman, R. N., Giacca, A., & Lewis, G. F. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.276.6.e1055 · Cited by 254
Zhou, Y. P. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.5.1584 · Cited by 241
Increased Insulin Concentrations in Nondiabetic Offspring of Diabetic Parents
Haffner, S. M., Stern, M. P., Hazuda, H. P., Mitchell, B. D., & Patterson, J. K. (1988) · New England Journal of Medicine · doi:10.1056/nejm198811173192001 · Cited by 238 · cited 1×
“Thus, re-examination of data from some other studies of high risk subjects with NGT would suggest that the conclusions in those papers disputing the presence of beta-cell dysfunction are erroneous because no difference in the insulin responses existed between groups despite the presence of insulin resistance, indicati…”
ResultHirose, H., Kawai, T., Yamamoto, Y., Taniyama, M., Tomita, M., Matsubara, K., Okazaki, Y., Ishii, T., Oguma, Y., Takei, I., et al. (2002) · Metabolism · doi:10.1053/meta.2002.30506 · Cited by 235 · cited 1×
“Of additional interest and in support of the role of intra-abdominal fat as a determinant of insulin sensitivity is the observation that the thiazolidinediones, which induce adipocyte differentiation [63], not only improve insulin sensitivity but also increase fat deposition in the subcutaneous rather than the intra-a…”
BackgroundImproved Glucose Tolerance with High Carbohydrate Feeding in Mild Diabetes
Brunzell, J. D., Lerner, R. L., Hazzard, W. R., Porte, D., & Bierman, E. L. (1971) · New England Journal of Medicine · doi:10.1056/nejm197103112841004 · Cited by 230
Kahn, S. E., & Halban, P. A. (1997) · Diabetes · doi:10.2337/diab.46.11.1725 · Cited by 221
Self-citationKahn, S. E., & Halban, P. A. (1997) · Diabetes · doi:10.2337/diabetes.46.11.1725 · Cited by 221
Self-citationPaolisso, G., Gambardella, A., Amato, L., Tortoriello, R., D'Amore, A., Varricchio, M., & D'Onofrio, F. (1995) · Diabetologia · doi:10.1007/bf00401761 · Cited by 217 · cited 1×
“Later, insulin concentrations are increased [152], similar [153] or somewhat decreased [154].”
BackgroundCavaghan, M. K., Ehrmann, D. A., Byrne, M. M., & Polonsky, K. S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119562 · Cited by 216
Pathophysiology of insulin secretion in non-insulin-dependent diabetes mellitus
Ward, W. K., Beard, J. C., Halter, J. B., Pfeifer, M. A., & Porte, D. (1984) · Diabetes Care · doi:10.2337/diacare.7.5.491 · Cited by 215
Obesity and insulin resistance: Lessons learned from the Pima indians
Lillioja, S., & Bogardus, C. (1988) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610040508 · Cited by 203 · cited 2×
“What has become apparent is that insulin sensitivity is influenced by a number of different factors such as genetics [20], age [21, 22], acute exercise [23], physical fitness [24], dietary nutrients [25], medications [26, 27, 28], obesity [9, 10, 29, 30, 31, 32] and body fat distribution [31, 33, 34, 35, 36, 37, 38].”
BackgroundEffect of exercise on insulin action, glucose tolerance, and insulin secretion in aging
Kahn, S. E., Larson, V. G., Beard, J. C., Cain, K. C., Fellingham, G. W., Schwartz, R. S., Veith, R. C., Stratton, J. R., Cerqueira, M. D., & Abrass, I. B. (1990) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1990.258.6.e937 · Cited by 198
Self-citationAssessing the potential for α-glucosidase inhibitors in prediabetic states
Holman, R. R. (1998) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(98)00038-2 · Cited by 197 · cited 3×
“The basis for progression in the UKPDS was examined using the Homeostasis Model Assessment (HOMA) which suggested that in this cohort of subjects with recently diagnosed Type 2 diabetes, an ongoing decline in beta-cell function without a change in insulin sensitivity was occurring [17, 18 ].”
BackgroundMethodInfluentialObesity, diabetes and the central nervous system
Porte Jr., D., Seeley, R. J., Woods, S. C., Baskin, D. G., Figlewicz, D. P., & Schwartz, M. W. (1998) · Diabetologia · doi:10.1007/s001250051002 · Cited by 186 · cited 1×
“Therefore, a deficiency of insulin action in the brain has the potential to increase body weight, which in turn would diminish insulin sensitivity [156].”
BackgroundDifferentiating Glucose Toxicity From Glucose Desensitization: A New Message From the Insulin Gene
Robertson, R. P., Olson, L. K., & Zhang, H.-J. (1994) · Diabetes · doi:10.2337/diab.43.9.1085 · Cited by 185
Kahn, S. E., Beard, J. C., Schwartz, M. W., Ward, W. K., Ding, H. L., Bergman, R. N., Taborsky, G. J., & Porte, D. (1989) · Diabetes · doi:10.2337/diab.38.5.562 · Cited by 181
Self-citationOlefsky, J., Farquhar, J. W., & Reaven, G. (1973) · Diabetes · doi:10.2337/diab.22.7.507 · Cited by 179
Cellular and Molecular Mechanisms of Non-Insulin Dependent Diabetes Mellitus
Kruszynska, Y. T., & Olefsky, J. M. (1996) · Journal of Investigative Medicine · doi:10.1177/108155899604400806 · Cited by 176
Yoshioka, N., Kuzuya, T., Matsuda, A., Taniguchi, M., & Iwamoto, Y. (1988) · Diabetologia · doi:10.1007/bf02341503 · Cited by 175
Pimenta, W. (1995) · JAMA · doi:10.1001/jama.1995.03520470063033 · Cited by 174 · cited 1×
“Studies in subjects at high risk including first degree relatives of subjects with Type 2 diabetes [121, 122], women with a history of gestational diabetes [100] or polycystic ovarian disease [96] and subjects with IGT [123, 124] have shown reductions in the later (second-phase) insulin response to intravenous glucose…”
BackgroundThe in vivo regulation of pulsatile insulin secretion
Pørksen, N. (2002) · Diabetologia · doi:10.1007/s125-002-8240-x · Cited by 174
Defects in Insulin Secretion and Action in Women With a History of Gestational Diabetes
Ryan, E. A., Imes, S. I., Liu, D., McManus, R., Finegood, D. T., Polonsky, K. S., & Sturis, J. (1995) · Diabetes · doi:10.2337/diab.44.5.506 · Cited by 171
Couillard, C., Mauriège, P., Prud’homme, D., Nadeau, A., Tremblay, A., Bouchard, C., & Després, J. (1997) · Diabetologia · doi:10.1007/s001250050804 · Cited by 171
Disproportionately Elevated Proinsulin in Pima Indians with Noninsulin-Dependent Diabetes Mellitus*
SAAD, M. F., KAHN, S. E., NELSON, R. G., PETTITT, D. J., KNOWLER, W. C., SCHWARTZ, M. W., KOWALYK, S., BENNETT, P. H., & PORTE, D. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-5-1247 · Cited by 167 · cited 1×
“Finally, inefficient proinsulin processing to insulin [77, 78, 79, 80, 81, 82, 83] and a reduction in the release of islet amyloid polypeptide (IAPP), known also as amylin [84, 85, 86, 87], have been observed in established Type 2 diabetes.”
BackgroundSelf-citationEffect of Weight Loss with Reduction of Intra-Abdominal Fat on Lipid Metabolism in Older Men
Purnell, J. Q. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.3.977 · Cited by 161 · cited 1×
“This reduction in fat mass was associated with a 24% reduction in intra-abdominal fat area, a 58% improvement in insulin sensitivity and the development of a less atherogenic lipid profile [61].”
BackgroundWard, W. K., Johnston, C. L. W., Beard, J. C., Benedetti, T. J., Halter, J. B., & Porte, D. (1985) · Diabetes · doi:10.2337/diab.34.9.861 · Cited by 159
Insulin Resistance and β-Cell Dysfunction in Aging: The Importance of Dietary Carbohydrate*
CHEN, M., BERGMAN, R. N., & PORTE, D. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-5-951 · Cited by 155 · cited 2×
“This effect is partly related to age, with aging being associated with a decline in the body’s responsiveness to carbohydrate [25, 49].”
BackgroundHöppener, J. W. M., Oosterwijk, C., Nieuwenhuis, M. G., Posthuma, G., Thijssen, J. H. H., Vroom, T. M., Ahrén, B., & Lips, C. J. M. (1999) · Diabetologia · doi:10.1007/s001250051175 · Cited by 153 · cited 15×
“We have confirmed this hypothesis in assessments of older subjects and first-degree relatives of subjects with Type 2 diabetes in whom a reduced IAPP response to glucose injection has been shown [106, 118].”
BackgroundInfluentialSanke, T., Hanabusa, T., Nakano, Y., Oki, C., Okai, K., Nishimura, S., Kondo, M., & Nanjo, K. (1991) · Diabetologia · doi:10.1007/bf00500385 · Cited by 149 · cited 2×
“Finally, inefficient proinsulin processing to insulin [77, 78, 79, 80, 81, 82, 83] and a reduction in the release of islet amyloid polypeptide (IAPP), known also as amylin [84, 85, 86, 87], have been observed in established Type 2 diabetes.”
BackgroundElbein, S. C., Hasstedt, S. J., Wegner, K., & Kahn, S. E. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.4.5604 · Cited by 143
Self-citationLongitudinal studies on the development of diabetes in individual Macaca nigra
Howard, C. F. (1986) · Diabetologia · doi:10.1007/bf00452067 · Cited by 141
Islet amyloid-associated diabetes in obese A(vy)/a mice expressing human islet amyloid polypeptide.
Soeller, W. C., Janson, J., Hart, S. E., Parker, J. C., Carty, M. D., Stevenson, R. W., Kreutter, D. K., & Butler, P. C. (1998) · Diabetes · doi:10.2337/diabetes.47.5.743 · Cited by 140 · cited 1×
“Studies using human IAPP transgenic mice suggest that consumption of increased dietary fat [133] or marked overproduction of IAPP [ 134 , 135] could be important factors in triggering the commencement of islet amyloidogenesis.”
BackgroundO'Meara, N. M., Sturis, J., Van Cauter, E., & Polonsky, K. S. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116560 · Cited by 132 · cited 16×
“In this large cohort, using recently defined criteria [127], only 45% had NGT with 36% meeting the criteria for IFG and/or IGT and 19% the criteria for diabetes.”
BackgroundInfluentialBuchanan, T. A., Xiang, A. H., Kjos, S. L., Trigo, E., Lee, W. P., & Peters, R. K. (1999) · Diabetes · doi:10.2337/diabetes.48.12.2430 · Cited by 129
Body Fat Distribution in Healthy Young and Older Men
Schwartz, R. S., Shuman, W. P., Bradbury, V. L., Cain, K. C., Fellingham, G. W., Beard, J. C., Kahn, S. E., Stratton, J. R., Cerqueira, M. D., & Abrass, I. B. (1990) · Journal of Gerontology · doi:10.1093/geronj/45.6.m181 · Cited by 122
Self-citationRimoin, D. L. (1967) · Diabetes · doi:10.2337/diab.16.5.346 · Cited by 122
Islet amyloid polypeptide in diabetic and non-diabetic Pima Indians
Clark, A., Saad, M. F., Nezzer, T., Uren, C., Knowler, W. C., Bennett, P. H., & Turner, R. C. (1990) · Diabetologia · doi:10.1007/bf00403322 · Cited by 119 · cited 1×
“One factor that we and others have been examining is the deposition of amyloid, which is found in the islets of up to 90% of patients with Type 2 diabetes [128, 129].”
BackgroundEnoki, S., Mitsukawa, T., Takemura, J., Nakazato, M., Aburaya, J., Toshimori, H., & Matsukara, S. (1992) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(92)90074-2 · Cited by 118
RADIOIMMUNOASSAY MAY OVERESTIMATE INSULIN IN NON‐INSULIN‐DEPENDENT DIABETICS
TEMPLE, R. C., CLARK, P. M. S., NAGI, D. K., SCHNEIDER, A. E., YUDKIN, J. S., & HALES, C. N. (1990) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1990.tb00915.x · Cited by 112
Elbein, S. C., Wegner, K., & Kahn, S. E. (2000) · Diabetes Care · doi:10.2337/diacare.23.2.221 · Cited by 109 · cited 1×
“Thus, first-degree relatives of patients with Type 2 diabetes [96, 97, 98], women with a history of gestational diabetes [99, 100, 101] or polycystic ovarian disease [96, 102], older subjects [22, 24, 103] and subjects with impaired glucose tolerance [104, 105] can all be shown to have beta-cell dysfunction, manifest…”
BackgroundSelf-citationBeard, J. C., Halter, J. B., Best, J. D., Pfeifer, M. A., & Porte, D. (1984) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1984.247.5.e592 · Cited by 109
Effects of individual fatty acids on glucose uptake and glycogen synthesis in soleus muscle in vitro
Thompson, A. L., Lim-Fraser, M. Y.-C., Kraegen, E. W., & Cooney, G. J. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.279.3.e577 · Cited by 107 · cited 1×
“Exposure to NEFA in vitro decreased insulin-mediated glucose uptake and glycogen synthesis [146] as well as reduced beta-cell function [147, 148], encompassing both reduced insulin release and impaired proinsulin to insulin processing.”
BackgroundImpaired postprandial glucose utilization in non-insulin-dependent diabetes mellitus
Kelley, D., Mokan, M., & Veneman, T. (1994) · Metabolism · doi:10.1016/0026-0495(94)90015-9 · Cited by 107 · cited 1×
“This reduction in the early insulin response results in a lack of adequate suppression of hepatic glucose production with subsequent post challenge hyperglycaemia and increased insulin concentrations late in the test [5, 126].”
BackgroundPeiris, A. N., Sothmann, M. S., Hennes, M. M. I., Lee, M., Wilson, C. R., Gustafson, A. B., & Kissebah, A. H. (1989) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/49.5.758 · Cited by 107
The Visceral Adiposity Syndrome in Japanese‐American Men
Fujimoto, W. Y., Abbate, S. L., Kahn, S. E., Hokansno, J. E., & Brunzell, J. D. (1994) · Obesity Research · doi:10.1002/j.1550-8528.1994.tb00076.x · Cited by 102
Self-citationZhou, Y. P., & Grill, V (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.5.7745004 · Cited by 100
Circulating proinsulin in patients with maturity onset diabetes
Mako, M. E., Starr, J. I., & Rubenstein, A. H. (1977) · The American Journal of Medicine · doi:10.1016/0002-9343(77)90538-1 · Cited by 99 · cited 1×
“Finally, inefficient proinsulin processing to insulin [77, 78, 79, 80, 81, 82, 83] and a reduction in the release of islet amyloid polypeptide (IAPP), known also as amylin [84, 85, 86, 87], have been observed in established Type 2 diabetes.”
BackgroundREGULATION OF INSULIN SECRETION
A., M. D., Wright, P. H., & Ashmore, J. (1969) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00999-8 · Cited by 99
Disorderly and nonstationary insulin secretion in relatives of patients with NIDDM
Schmitz, O., Porksen, N., Nyholm, B., Skjaerbaek, C., Butler, P. C., Veldhuis, J. D., & Pincus, S. M. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.272.2.e218 · Cited by 97
Insulin secretion and clearance during low-dose graded glucose infusion
Byrne, M. M., Sturis, J., & Polonsky, K. S. (1995) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1995.268.1.e21 · Cited by 96
A common variant in PPP1R3 associated with insulin resistance and type 2 diabetes.
Xia, J., Scherer, S. W., Cohen, P. T., Majer, M., Xi, T., Norman, R. A., Knowler, W. C., Bogardus, C., & Prochazka, M. (1998) · Diabetes · doi:10.2337/diabetes.47.9.1519 · Cited by 86
Exercise and physical training: Effects on insulin sensitivity and glucose metabolism
Horton, E. S. (1986) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610020101 · Cited by 86
Hansen, L., Hansen, T., Vestergaard, H., Bjørbæk, C., Echwald, S. M., Clausen, J. O., Chen, Y. H., Chen, M. X., Cohen, P. T. W., & Pedersen, O. (1995) · Human Molecular Genetics · doi:10.1093/hmg/4.8.1313 · Cited by 84
Adaptation of B and A cell function during prolonged glucose infusion in human subjects
Ward, W. K., Halter, J. B., Beard, J. C., & Porte, D. (1984) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1984.246.5.e405 · Cited by 83
Decrease of Stimulated Amylin Release Precedes Impairment of Insulin Secretion in Type II Diabetes
Ludvik, B., Lell, B., Hartter, E., Schnack, C., & Prager, R. (1991) · Diabetes · doi:10.2337/diab.40.12.1615 · Cited by 82
Hasstedt, S. J., Ren, Q.-F., Teng, K., & Elbein, S. C. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7205 · Cited by 81
Wang, F., Hull, R. L., Vidal, J., Cnop, M., & Kahn, S. E. (2001) · Diabetes · doi:10.2337/diabetes.50.11.2514 · Cited by 77 · cited 1×
“Work done on non-human primates [136] and transgenic mice [137] support the concept that islet amyloid deposition is an early event in the pathogenesis of Type 2 diabetes being associated with reductions in insulin release well before the onset of hyperglycaemia.”
BackgroundSelf-citationRelationship of Islet Function to Insulin Action in Human Obesity*
BEARD, J. C., WARD, W. K., WALLUM, B. J., & PORTE, D. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-65-1-59 · Cited by 75
Kahn, S. E., Verchere, C. B., Andrikopoulos, S., Asberry, P. J., Leonetti, D. L., Wahl, P. W., Boyko, E. J., Schwartz, R. S., Newell-Morris, L., & Fujimoto, W. Y. (1998) · Diabetes · doi:10.2337/diabetes.47.4.640 · Cited by 74 · cited 18×
“In this large cohort, using recently defined criteria [127], only 45% had NGT with 36% meeting the criteria for IFG and/or IGT and 19% the criteria for diabetes.”
BackgroundInfluentialSelf-citationKahn, S. E. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.4.1399 · Cited by 68
Self-citationFerroni, P., Basili, S., Martini, F., et al. (2000) · Journal of Investigative Medicine · doi:10.1177/1081558900048001010 · Cited by 63
Larsson, H. E., & Ahr�n, B. (1996) · Diabetologia · doi:10.1007/bf00400660 · Cited by 60
Larsson, H., & Ahr�n, B. (1996) · Diabetologia · doi:10.1007/s001250050559 · Cited by 60
The Role of Dietary Carbohydrate in the Decreased Glucose Tolerance of the Elderly
Chen, M., Halter, J. B., & Porte, D. (1987) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1987.tb04663.x · Cited by 59
Kahn, S. E. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.74.6.1336 · Cited by 59
Self-citationEarly insulin responses to glucose and to tolbutamide in maturity-onset diabetes
Varsano-Aharon, N., Echemendia, E., Yalow, R. S., & Berson, S. A. (1970) · Metabolism · doi:10.1016/0026-0495(70)90092-2 · Cited by 58
Human aging is associated with parallel reductions in insulin and amylin release
Dechenes, C. J., Verchere, C. B., Andrikopoulos, S., & Kahn, S. E. (1998) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1998.275.5.e785 · Cited by 55
Self-citationKnowles, N. G., Landchild, M. A., Fujimoto, W. Y., & Kahn, S. E. (2002) · Diabetes Care · doi:10.2337/diacare.25.2.292 · Cited by 51 · cited 3×
“We have confirmed this hypothesis in assessments of older subjects and first-degree relatives of subjects with Type 2 diabetes in whom a reduced IAPP response to glucose injection has been shown [106, 118].”
BackgroundResultSelf-citationIslet dysfunction in obese women with impaired glucose tolerance
Larsson, H., & Ahrén, B. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90227-9 · Cited by 44 · cited 1×
“Thus, first-degree relatives of patients with Type 2 diabetes [96, 97, 98], women with a history of gestational diabetes [99, 100, 101] or polycystic ovarian disease [96, 102], older subjects [22, 24, 103] and subjects with impaired glucose tolerance [104, 105] can all be shown to have beta-cell dysfunction, manifest…”
BackgroundHalter, J. B., & Porte, D. (1978) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-46-6-952 · Cited by 41
Kahn, S. E., Bergman, R. N., Schwartz, M. W., Taborsky, G. J., & Porte, D. (1992) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1992.262.4.e518 · Cited by 37
Self-citationBasal and stimulated hyperinsulinism: reversible metabolic sequelae of obesity.
Jd, B., Porte, D., Jd, B., & El, B. (1974) · PubMed · Cited by 37
Prigeon, R. L., Kahn, S. E., & Porte, D. (1995) · Metabolism · doi:10.1016/0026-0495(95)90026-8 · Cited by 30
Self-citationGlucose Stimulates and Potentiates Islet Amyloid Polypeptide Secretion by the B-Cell
Kahn, S., Fujimoto, W., D'Alessio, D., Ensinck, J., & Porte, D. (1991) · Hormone and Metabolic Research · doi:10.1055/s-2007-1003759 · Cited by 28
Self-citationHegele, R. A., Harris, S. B., Zinman, B., Wang, J., Cao, H., Hanley, A. J., Tsui, L., & Scherer, S. W. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.11.5219 · Cited by 28
Effects of Arginine on the Secretion of Insulin and Islet Amyloid Polypeptide in Humans
Larsson, H., & Ahrén, B. (1995) · Pancreas · doi:10.1097/00006676-199508000-00015 · Cited by 22
Hansen, L., Reneland, R., Berglund, L., Rasmussen, S. K., Hansen, T., Lithell, H., & Pedersen, O. (2000) · Diabetes · doi:10.2337/diabetes.49.2.298 · Cited by 22 · cited 1×
“Examination of groups of healthy subjects in a number of different populations has shown that known genetic mutations associated with insulin resistance are rare [20, 39, 40, 41, 42, 43, 44].”
BackgroundCa(2+)-insensitive sustained contraction of skinned smooth muscle after acidic ADP treatment
Morimoto, S., & Ogawa, Y. (1995) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1995.268.1.c21 · Cited by 18
Proinsulin, C-peptide, and insulin in normal subjects during an 8-h hyperglycemic clamp
Hartling, S. G., Røder, M. E., Dinesen, B., & Binder, C. (1996) · European Journal of Endocrinology · doi:10.1530/eje.0.1340197 · Cited by 16
Regulation of Insulin Secretion in Vivo
Vidal, J., & Kahn, S. E. (2001) · Endocrine updates · doi:10.1007/978-1-4615-1597-5_7 · Cited by 7
Self-citationUKPDS 26: sulphonylurea failure in non-insulin-dependent diabetic patients over six years
UK Prospective Diabetes Study (UKPDS) Group, Matthews, D. R., Cull, C. A., Stratton, I. M., Holman, R. R., & Turner, R. C. (1998) · Diabetic Medicine · doi:10.1002/(sici)1096-9136(199804)15:4
Research works printed but not linked: 2
- 97. Kahn SE (1996) Regulation of B-cell function in vivo: from health to disease. Diabetes Rev 4:372-389
- 120. Landchild MJ, Knowles NG, Yao Q et al. (2000) Increased β -cell secretory demand is not the simple explanation for inefficient proinsulin processing and islet amyloid formation in type 2 diabetes. J Investig Med 48:21A (Abstract)
Cited by
The metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Mechanisms linking obesity to insulin resistance and type 2 diabetes
Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006) · Nature · doi:10.1038/nature05482 · Cited by 5,448
Self-citationCosentino, F., Grant, P. J., Aboyans, V., Bailey, C. J., Ceriello, A., Delgado, V., Federici, M., Filippatos, G., Grobbee, D. E., Hansen, T. B., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz486 · Cited by 4,763
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2012) · Diabetologia · doi:10.1007/s00125-012-2534-0 · Cited by 3,919
“Indeed, while matching a drug’s mechanism of action to the underlying causes of hyperglycaemia in a specific patient seems logical, there are few data that compare strategies based on this approach [109].”
BackgroundManagement of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2012) · Diabetes Care · doi:10.2337/dc12-0413 · Cited by 3,207
Metadata
- Authors
- Kahn, S. E.
- Affiliations
- University of Washington (US)
- Corresponding author
- Kahn, S. E.
- ORCID
- Kahn, S. E.
- Venue
- Diabetologia
- Published
- 2003-01
- Volume
- 46
- Issue
- 1
- Pages
- 3-19
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2004014076
- Cited by
- 2,166
- References
- 177
- Citations by year
- 2026: 45 · 2025: 54 · 2024: 88 · 2023: 85 · 2022: 99 · 2021: 105 · 2020: 110 · 2019: 95 · 2018: 109 · 2017: 105 · 2016: 90 · 2015: 110 · 2014: 134 · 2013: 120 · 2012: 95
- FWCI
- 13.10
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs (DK-17047)
- National Institutes of Health (RR-37)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK050703, K24DK002654, DK50703, DK 02654, DK-17047, P30DK017047)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- type 2 diabetes, insulin resistance, beta-cell dysfunction, insulin sensitivity, insulin secretion, hyperbolic relationship, beta-cell mass, intra-abdominal fat, body fat distribution, oral glucose tolerance, impaired glucose tolerance, genetic susceptibility, disease prevention
- MeSH terms
- Adipose Tissue, Diabetes Mellitus, Type 2, Humans, Insulin, Insulin Resistance, Islets of Langerhans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-04, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-04 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.